Glucose-sensitive nanoparticle for cancer diagnosis and therapy
US-2015374828-A1 · Dec 31, 2015 · US
US9011920B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9011920-B2 |
| Application number | US-200913131903-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2009 |
| Priority date | Dec 6, 2008 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to transport mediator-bonded colloids comprising pharmaceutical substances or fluorescence markers, to a method for the production thereof, and to a pharmaceutical preparation comprising said compounds.
Opening claim text (preview).
The invention claimed is: 1. A compound of general formula (I) (T-Z) n —P (I), wherein T is a transport mediator in the form of heparin or a heparin derivative; P is a colloid-active compound selected from the group consisting of hydroxyalkyl starches and carboxyalkyl starches; Z is a first linker by means of which T and P are covalently linked together; and n is an integer of at least 1; and wherein the transport mediator T and/or the colloid P is linked with m g…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.